Biodesix, Inc.’s Post

In this video roundtable discussion, Jaspal Singh, MD, MHA, MHS, interviews Jasleen Pannu, MD, Coral Giovacchini, MD, and Leisa Lackey about the design, growth, and importance of incidental lung nodule programs, including software programs used and a business argument for including a lung nodule program navigator to assist in patient care. This is part two of a three-part series on lung cancer screening. Watch the roundtable here: https://okt.to/QRyN21

Lung cancer remains one of the most prevalent forms of Cancer worldwide, often diagnosed at a late stage when treatment options are more limited. This World Lung Cancer Day, by fostering a greater understanding of the disease and supporting efforts to combat it, we at COD aim to advance clinical research and drug development, and to emphasize the importance of early detection. To know more about us, write to us at bd@cod-research.com Designing Therapies for Future #WorldLungCancerDay2024 #WLCD24 #ClosetheCareGap #EveryoneDeservesAccesstoCancerCare #CODResearch

Today marks World Lung Cancer Day, a day of reflection and awareness on how lung cancer has impacted many lives. We want to emphasize the importance of early detection, screening, diagnosis, and personalized treatment plans, which can improve patient outcomes. Learn more about the State of Lung Cancer from the American Lung Association: https://lnkd.in/gAA9vamc  #WLCD24 #biodesix #lungcancer #diagnostics #biomarkers

Time is a critical factor in treating lung cancer, and a new study offers promising news. Researchers led by Dr. Miguel García-Pardo at Princess Margaret Cancer Centre have demonstrated that liquid biopsies can expedite treatment initiation for advanced non–small cell lung cancer patients. The study found that liquid biopsy, combined with traditional tissue biopsy, enabled patients to start treatment 23 days earlier on average. At Biodesix, Inc., our IQLung Treatment Guidance testing suite delivers comprehensive molecular results in just 3 business days, enabling swift, informed decisions for NSCLC patients. 🔗 Learn more about IQLung testing at https://okt.to/2DnQHL Let's redefine precision diagnostics together! #LungCancer #LiquidBiopsy #ctDNA #NSCLC #IQLung #Biodesix

In a trailblazing move to improve cancer care, a panel discussion titled ‘Cancer Moonshots Across the Continuum’ was recently held, moderated by #JPMorgan. The panel focused on strategies to cut the cost of cancer care and the mortality rate in half. This article delves into the key takeaways from this impactful discussion and the consequent implications for the future of cancer care.

In a trailblazing move to improve cancer care, a panel discussion titled ‘Cancer Moonshots Across the Continuum’ was recently held, moderated by #JPMorgan. The panel focused on strategies to cut the cost of cancer care and the mortality rate in half. This article delves into the key takeaways from this impactful discussion and the consequent implications for the future of cancer care.

🗓️August is World Lung Cancer Day 🫁 Through the Time to Accelerate: for Cancer Screening campaign ECO is uniting medical societies and patient groups to implement and update national screening strategies across the EU. Read more 🔗 https://lnkd.in/dUAGi_pS Together, we can make a difference! #EUCancerPlan

In a trailblazing move to improve cancer care, a panel discussion titled ‘Cancer Moonshots Across the Continuum’ was recently held, moderated by #JPMorgan. The panel focused on strategies to cut the cost of cancer care and the mortality rate in half. This article delves into the key takeaways from this impactful discussion and the consequent implications for the future of cancer care.

In a trailblazing move to improve cancer care, a panel discussion titled ‘Cancer Moonshots Across the Continuum’ was recently held, moderated by #JPMorgan. The panel focused on strategies to cut the cost of cancer care and the mortality rate in half. This article delves into the key takeaways from this impactful discussion and the consequent implications for the future of cancer care.

In a trailblazing move to improve cancer care, a panel discussion titled ‘Cancer Moonshots Across the Continuum’ was recently held, moderated by #JPMorgan. The panel focused on strategies to cut the cost of cancer care and the mortality rate in half. This article delves into the key takeaways from this impactful discussion and the consequent implications for the future of cancer care.